GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kuros Biosciences Ltd (XSWX:KURN) » Definitions » Price-to-Tangible-Book
中文

Kuros Biosciences (XSWX:KURN) Price-to-Tangible-Book

: 18.97 (As of Today)
View and export this data going back to 2002. Start your Free Trial

As of today (2024-04-23), Kuros Biosciences's share price is CHF8.12. Kuros Biosciences's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was CHF0.43. Hence, Kuros Biosciences's Price to Tangible Book Ratio of today is 18.97.

The historical rank and industry rank for Kuros Biosciences's Price-to-Tangible-Book or its related term are showing as below:

XSWX:KURN' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.45   Med: 3.42   Max: 18.88
Current: 18.88

During the past 13 years, Kuros Biosciences's highest Price to Tangible Book Ratio was 18.88. The lowest was 2.45. And the median was 3.42.

XSWX:KURN's Price-to-Tangible-Book is ranked worse than
95.02% of 703 companies
in the Medical Devices & Instruments industry
Industry Median: 2.63 vs XSWX:KURN: 18.88

A closely related ratio is called PB Ratio. As of today, Kuros Biosciences's share price is CHF8.12. Kuros Biosciences's Book Value per Sharefor the quarter that ended in Dec. 2023 was CHF1.54. Hence, Kuros Biosciences's P/B Ratio of today is 5.27.


Kuros Biosciences Price-to-Tangible-Book Historical Data

The historical data trend for Kuros Biosciences's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kuros Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.42 2.45 3.01 2.67 8.15

Kuros Biosciences Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.01 3.13 2.67 3.09 8.15

Competitive Comparison

For the Medical Devices subindustry, Kuros Biosciences's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kuros Biosciences Price-to-Tangible-Book Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Kuros Biosciences's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Kuros Biosciences's Price-to-Tangible-Book falls into.



Kuros Biosciences Price-to-Tangible-Book Calculation

Kuros Biosciences's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=8.12/0.428
=18.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Kuros Biosciences Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Kuros Biosciences's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Kuros Biosciences (XSWX:KURN) Business Description

Traded in Other Exchanges
Address
Wagistrasse 25, Schlieren, Zurich, CHE, 8952
Kuros Biosciences Ltd is a Swiss-based biopharmaceutical company focused on the development of innovative products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment includes products such as Fibrin-PTH, a drug-biologic combination that promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and increasing the lifespan of bone-forming cells. The Legacy portfolio segment includes all other products that do not belong to the group's core business strategy.

Kuros Biosciences (XSWX:KURN) Headlines

No Headlines